Studies indicate that the incidence of hypoglycemia among the insulin-treated T2D population is about one-third of that seen in patients with T1D but the greater number of patients with T2D means that a greater number of these patients may suffer a hypoglycemic event, especially in patients with a longer duration of diabetes [6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.